Vimarsana
Biggest News Aggregation in the World

Page 8 - Evercore Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evercore Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evercore Inc Today - Breaking & Trending Today

Evercore Reports Fourth Quarter and Full Year 2023 Results; Quarterly Dividend of $0.76 Per Share - Vimarsana News

Evercore Reports Fourth Quarter and Full Year 2023 Results; Quarterly Dividend of $0.76 Per Share

Evercore Inc. : Fourth Quarter Results   Full Year Results   U.S. GAAP   ...

North American Morning Briefing : Big Tech Weighs -2- - 2024-01-31 - Vimarsana News

North American Morning Briefing : Big Tech Weighs -2- - 2024-01-31

The muted activity in China's manufacturing sector suggests a soft start to the year, and highlights the limits of Chinese leaders' attempt to double down on manufacturing to drive the economy as... -January 31, 2024 at 06:20 am EST - MarketScreener

Sun Life Financial (TSE:SLF) Price Target Raised to C$78.00 at Evercore - Vimarsana News

Sun Life Financial (TSE:SLF) Price Target Raised to C$78.00 at Evercore

Sun Life Financial (TSE:SLF – Free Report) (NYSE:SLF) had its price target upped by Evercore from C$76.00 to C$78.00 in a research note issued to investors on Tuesday morning, BayStreet.CA reports. Evercore currently has an outperform rating on the financial services provider’s stock. A number of other analysts have also recently commented on SLF. Desjardins […]

Real estate opportunities attract private equity billionaire David Rubenstein - Vimarsana News

Real estate opportunities attract private equity billionaire David Rubenstein

The leveraged buyout legend is raising $400 million for multifamily housing and industrial properties, sources say.

Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio - Vimarsana News

Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio

Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc.® (“Mirati”). With the completion of the acquisition, Mirati shares have ceased trading on the NASDAQ Global Select Market and Mirati is now a wholly owned subsidiary of Bristol Myers ...